samhocking said:
Thanks for the explanation MI. I was thinking of the levels being so high at start of stage/night before from a transfusion, that he would be close to him having cardiac problems, but is sounds like the dose is relatively within range to still function normally.
I believe it’s within the range for many people to function more or less normally. Individuals differ, of course.
It seems the circumstances are pointing towards salbutomol not being a mistake from a transfusion while loosing weight like we assume it's' normally used for, but being used to enhance performance in some way we don't know about during the race then?
Probably used for recovery. That seems to be the best guess.
Salbutomol's elimination half-life in the urine is 2.7 - 5.5 hours. Stage 18 was only 4 hours long. If we say he took it orally in the morning another 4 hours before the stage, his half-life window would be around 8 hours meaning the 2000 reading after the stage would actually only have needed that other 4 hours to drop to around the 1000 mark and so in the clear.
The half-life depends on how it’s taken. It’s excreted faster following inhalation, about 2.5 hour half-life from what I’ve heard. More like four hours, more or less, following an oral dose. And these are averages, of course. Individuals may have significantly shorter or longer values.
If I was betting on what I think now, I would say his oral dosage is him doing this privately, but real asthma hit him, team doctor administered a higher dose than normal, knowing there's a fairly big cushion before getting anywhere near the 1000 mark, Froome couldn't exactly say, sorry i've been self administering oral (not allowed) salbutomol without telling you and what the doctor gave him, was just enough on a short stage to trip anti-doping. End of the day had he taken the pill 2 hours earlier and the stage be 2 hours longer his reading would be around the 1000 level including what the Team doctors increased dose.
That scenario, more or less, has occurred to me, but someone as familiar with salbutamol as Froome must be (even if he’s only been taking it for a few years, as I suspect may be the case, that’s still enough time to understand the relationship between dose and urine levels very well) shouldn’t be tripped up in this manner. If he’s been dosing orally successfully, he’s learned to take doses that allow at least some puffs on the inhaler. A few extra puffs, particularly if taken at the end of the stage, soon before testing, might add a few hundred ng/ml to his urine level, but the total should still be nowhere near 2000. Even if, hypothetically, he had been oral dosing and not taking any puffs at all, and started inhaling for the very first time on this stage, and took the entire allowed dose of 800 ug after finishing the stage—that still would likely not be enough to get him to 2000 if his oral dosing alone kept him below 1000. I think something else must be going on.
What? As I’ve emphasized before, if and when he urinates on a stage could be critical. Urine concentrations peak at one hour following inhalation. The kinetics following oral doses are a little slower, and I’ve been unable to access a study that provides them, but let’s make an estimate, using your eight hour period and a half life of four hours. Let’s assume that after four hours, his urine level is 2000 ng/ml, and he urinated then. After another four hours, his level might be approximately 1000 ng/ml.
Now suppose he didn’t urinate after four hours, but only after eight hours. His salbutamol level would be about 1500 ng/ml, the mean of the two levels assuming constant urine flow. So by not relieving himself, he’s increased his urine level by about 50%, or 500 ng/ml. Moreover, the effect can be even greater if he urinates sooner. E.g., suppose he orally dosed at the start of the stage. If he didn’t stop during the stage, his level in this example would be 2000 ng/ml. If he stopped after two hours, his level at that point might be roughly 3000 ng./ml, and if then urinated again, at the end of the stage, it would be about 1000 ng/ml. So now he’s actually doubled his level, from the threshold to the value that has been reported, just by not stopping along the way.
This is a very rough estimate, I really need to see actual data, but it gives you an idea of how much of an effect not urinating before the end of the stage can have. Other factors, like taking extra puffs, particularly after the stage is over, will further contribute, but the real game changer is whether he stops to pee.
The main problem I have with this explanation is that it’s hard to believe he wouldn’t be aware of this. If he didn’t stop to urinate on this stage, it’s probably happened before, and even if in the past when this happened he had a cushion, so to speak, and didn’t exceed the threshold, I would think it would have taught him not to push the envelope—to take doses that will not trigger the threshold even if he can’t stop to urinate. It would obviously be very foolish to plan the dose based on an event you can't guarantee ahead of time will happen.
However, the time at which he urinates is also critical. Generally speaking, the later, the better. if he couldn’t do it at the time he wanted--let's say that race tactics dictated he stop sooner than he would have preferred--his level would be higher than otherwise. Not that much higher, but now he would be somewhat more vulnerable to the effects of extra puffs and the effects of deyhdration, which might raise his levels higher than anticipated.
Edit: OK, I finally accessed that full paper:
http://sci-hub.la/10.1249/MSS.0b013e3181b2e87d
The urinary levels of slabutamol following a four mg oral dose actually didn't drop that much from 4-8 hours, though there was large individual variation. There was a much larger drop from 8-12 hours:
0-4 hr 2400 ng/ml (estimated from bar graph)
4-8 hr 2200 ng/ml
8-12 hr 1200 ng/ml
Even from these data, though, one can see the potential that urinating during a stage might have on levels at the end of the stage. There was a large amount of individual variation, and 3/10 subjects showed a drop of 50% or more from 0-4 hr to 4-8 hr. Another study by the same group showed, again, a relatively small drop from 0-4 hr vs. 4-8 hr, but an even larger drop to 8-12 hr, about 67%. Still another study, by a different group,reported a drop of about one-third, from about 1650 ng/ml in 0-6 hours to about 1100 in 6-12 hours. So depending on factors such as how long before the stage an oral dose was taken, and the individual, a very large difference is certainly plausible.